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Abstract
Background: Crete has been of great epidemiological interest ever since the publication of the
Seven Countries Study. In 1988 a well-defined area of rural Crete was studied, with only scarce
signs of coronary heart disease (CHD) despite the unfavorable risk profile. The same population
was re-examined twelve years later aiming to describe the trends of CHD risk factors over time
and discuss some key points on the natural course of coronary heart disease in a rural population
of Crete.
Methods and Results: We re-examined 200 subjects (80.7% of those still living in the area, 62.4
± 17.0 years old). The prevalence of risk factors for CHD was high with 65.9% of men and 65.1%
of women being hypertensive, 14.3% of men and 16.5% of women being diabetic, 44% of men being
active smokers and more than 40% of both sexes having hyperlipidaemia. Accordingly, 77.5% of the
population had a calculated Framingham Risk Score (FRS) ≥ 15%, significantly higher compared to
baseline (p < 0.001). The overall occurrence rate for CHD events was calculated at 7.1 per 1000
person-years (95% confidence interval: 6.8–7.3).
Conclusion:  The study confirms the unfavorable risk factor profile of a well defined rural
population in Crete. Its actual effect on the observed incidence of coronary events in Cretans
remains yet to be defined.
Background
The population of Crete has been a subject of great epide-
miological interest ever since the Seven Countries Study
on cardiovascular diseases reported markedly lower mor-
tality rates for the Cretan cohort, among the 16 initially
investigated [1-5]. World Health Organization statistical
reports referring to that era are consistent with a lower
incidence of coronary heart disease(CHD) in the popula-
tion [6]. However, we currently have sufficient evidence to
support that the natural course of CHD [7] and the cardi-
ovascular risk profile of the population have changed [8-
11]. This is mainly attributed to dietary and life-style mod-
ifications that have taken place in Crete over the last dec-
ades [12-14].
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A research project in primary health care was established
in 1988, in a rural area of Crete, aiming to identify the car-
diovascular risk profile of a pre-defined "low risk" popu-
lation [15]. The main findings that emerged from this
study involved an extremely high prevalence of smoking
(particularly among men), hypertension, diabetes and a
high occurrence of alcohol intake. Most of the population
was found to be obese and presented increased choles-
terol levels. Surprisingly, and against this unfavorable risk
profile, signs of coronary artery disease were scarce, with
only three men fulfilling definite criteria of a previous
myocardial infarction [15]. Lacking a certain explanation
for this "paradox", the authors suggested a possible car-
dio-protective role related to the closely-knit social net-
work, the low unemployment rates and the potential
benefit of certain dietary habits (e.g. the high consump-
tion of olive oil). Their hypothesis, regarding the presence
of a health asset in the community, was further supported
by the observation that other Mediterranean countries
(Italy, Spain, Portugal, France) sharing many common
cultural and dietary characteristics, also ranked at the bot-
tom in the list of cardiovascular morbidity and mortality
[16]. Atherosclerosis, however, is a chronic and progres-
sive disease taking decades prior to its clinical presenta-
tion [17]. Therefore, the low incidence of ischemic heart
disease among men of Crete described in 1988 could sim-
ply represent the beneficial inheritance of a healthier way
of living in the past. On the other hand, the impact of this
emerging unfavorable risk profile, also identified by other
investigators [12], would only be adequately assessed 15
to 20 years later.
To highlight these controversies and explore this Cretan
"paradox" we decided to carry-out a follow up study
involving all inhabitants of the rural area of Spili, in the
island of Crete, twelve years after their initial examina-
tion, in 1988. The aim of this paper was to describe the
trends of CHD risk factors over time and discuss some key
points on the natural course of coronary heart disease in
this particular rural population of Crete.
Methods
Setting and subjects
The study population consisted of all men and women,
originally examined in 1988 (n = 333), still living in the
rural area of Spili in Crete (Figure 1). The project was
launched on September 2000 and was gradually com-
pleted over a 15-month period. Thirty-seven subjects of
the initial population had meanwhile left the area, while
48 (25 males) had died. Most of the people who had left
the village were living either in one of the major cities of
the island or in Athens, the reasoning for this internal
migration being mainly studies or better professional
opportunities. The district nurses and staff of the local
Health Centre proved a valuable source of information
tracking down each one of the members of the initial pop-
ulation. A total of 248 inhabitants, who participated in
the first phase of the study and currently live in the area,
represented the target group for the re-examination. They
were all given both a formal invitation letter to participate
in the study and personally approached by the district
nurses. For those deceased, their death certificates and
medical records, retrieved from the Health Centre's
archive, provided valuable information regarding mor-
bidity and mortality indices of the population. Our study
complied with the Declaration of Helsinki while the
research protocol was approved by the Ethics Committee
of the University Hospital of Crete. All participants pro-
vided an informed written consent.
Medical history and clinical examination
A complete medical history was obtained for each one of
the participants. For reasons of comparability to the base-
line study, we used the initial questionnaire that was fur-
ther enriched with topics regarding the subjects'
performance status (Boston score, NYHA class) and cardi-
ovascular morbidity over the last decade.
The 10-year Framingham Risk Score (FRS) was calculated
for all subjects participating in the first phase of the study,
who were free of clinically evident cardiovascular disease
(ischemic heart disease, stroke, peripheral vascular dis-
ease, heart failure) at baseline examination [18]. The same
risk score was re-calculated at follow up (2001), based on
the contemporary values of its determinants. Subjects
were classified, according to current guidelines [19], into
low (<15%), medium (15–25%) and high (>25%) risk
categories for developing coronary heart disease (fatal and
non-fatal myocardial infarction, unstable angina or
angina pectoris) in the following ten years. Data regarding
CHD morbidity, defined as non fatal myocardial infarc-
tion, unstable angina or angina pectoris, were obtained
both through the personal interview during re-examina-
tion and through reviewing medical records, kept in the
Health Centre's database, for each one of the participants.
In most of the cases, a typical medical history of chest pain
was associated either with a record of admission to the
regional hospital and a discharge diagnosis of coronary
artery disease, or a thorough (according to current practice
guidelines [20,21]) invasive or non-invasive evaluation,
leading to the diagnosis. Both an electronic and a hard
copy of patients' records were available at the local Health
Centre [15]. For those deceased, the death certificates were
obtained and the cause of death was analyzed and classi-
fied according to ICD-9 [22]. A CHD death was defined
either as a fatal myocardial infarction or as a sudden death
with a positive post mortem examination.BMC Public Health 2007, 7:351 http://www.biomedcentral.com/1471-2458/7/351
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Blood pressure assessment – electrocardiogram
Blood pressure (BP) was assessed for all participants, fol-
lowing a standardized procedure, according to Joint
National Committee (JNC) 7 guidelines [23]. Measure-
ments were taken at the end of the interview with the
patient seated quietly for at least 5 minutes, feet on the
floor and arm supported at heart level. An appropriate
sized cuff (with a cuff bladder encircling at least 80% of
the arm) was used along with a standard mercury sphyg-
momanometer. The BP was measured in both arms and in
case of a difference the reading from the arm with the
higher BP was taken into account. For diastolic BP (DBP)
Korotkoff phase V was considered. At least two BP meas-
urements were acquired from each patient with more than
1-min interval among them and the mean value was
recorded.
An electrocardiogram (ECG) was obtained for all subjects
(Cardiette excel 106 SCP, Elettronica Trentina s.p.s, Cavar-
eno Italy) and was digitally stored in the Practice's data-
base for further analysis.
Laboratory and somatometric variables
A blood sample was obtained with the patients fasting
overnight. Serum was separated and analyzed for glucose,
lipids (total cholesterol, HDL, triglycerides), creatinine
and γ-Gt. The remaining serum was then frozen at -80°C
and kept for subsequent analyses. All analyses were car-
ried out in the local Practice's laboratory (Dry chemistry
analyzer Spotchem SP-4410, Menarini, Italy). External
quality control for the Practice's lab is routinely carried
out twice a year. To further ensure the reliability of our
measurements, we conducted an additional external qual-
Study population Figure 1
Study population. Study population presented schematically. The signs  and  represent men and women respectively.BMC Public Health 2007, 7:351 http://www.biomedcentral.com/1471-2458/7/351
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ity control, for a subset of randomly selected specimens,
using the laboratory of the University Hospital of Crete as
a reference; the standard deviation index (SDI, defined as
[lab mean - peer group mean]/peer group standard devia-
tion) was found well below the values of ± 1, as expected.
Weight, height, waist and hip measurements were
assessed, as previously described [15]. Body mass index
(BMI = weight/height squared, kg/m2) and waist to hip
ratio were calculated. Smoking habits were recorded
through an interview and subjects were classified into
non-smokers, ex-smokers (cessation for more than 12
months) and currently active smokers.
Diagnostic criteria
Hypertension was defined as systolic BP (SBP) ≥ 140
mmHg or diastolic BP (DBP) ≥ 90 mmHg or current treat-
ment with antihypertensive drugs, according to JNC 7
[23]. Awareness of hypertension reflects the subject's
knowledge of being hypertensive based on a previous
diagnosis. Treatment of hypertension was defined as cur-
rent use of antihypertensive drugs. Patients who reported
a positive or uncertain history of hypertension and had BP
below those thresholds without receiving treatment were
classified as normotensives. For reasons of comparability,
the prevalence of hypertension in 1988 was re-evaluated
using current guidelines for its definition.
The diagnosis of diabetes mellitus was based either on a
positive medical history, regardless whether the patient
was on treatment or not, or on a fasting blood glucose
concentration of 126 mg/dL (7.0 mmol/L) or higher, or
on a random value of 200 mg/dL (11.1 mmol/L) or higher
(confirmed by repeating) and on reporting classic symp-
toms of hyperglycemia (thirst, polyuria, weight loss, vis-
ual blurring) [24]. Again, the current diagnostic criteria
were used to re-assess the prevalence of diabetes in the
1988 data.
National Cholesterol Education Program guidelines –
NCEP III (Adult Treatment Panel [ATP] III) were used to
assess the prevalence of hypercholesterolemia in the pop-
ulation [19]. For patients without known medical history
of cardiovascular disease, a total cholesterol value ≥ 200
mg/dl was considered as reason for intervention (usually
dietary).
Overweight patients were defined as those with a BMI
value  ≥ 25 kg/m2, while the criterion for obesity and
extreme obesity was ≥ 30 and ≥ 40 kg/m2 respectively [25-
27]. The prevalence of abdominal obesity was assessed by
measuring waist circumference; according to current prac-
tice guidelines a value greater than 102 cm for men and 88
cm for women was considered indicative of central type
obesity [25].
Statistical analysis
Statistical analyses were performed by a statistician (A.A.)
using the Statistical Package for Social Science (SPSS ver-
sion 13.0) for Windows. Continuous variables were
expressed as mean ± standard deviation (SD) while dis-
crete ones as counts and proportions. Paired samples t-test
was used for two group's comparisons. Associations
between categorical variables were measured using Pear-
son's chi-square statistic (Mantel-Haesnzel for ordinal),
while McNemar's or McNemar-Bowker χ2-statistic was
assessed to estimate changes in proportions between
phase 1 and phase 2 variables such as smoking hyperlipi-
daemia, etc.
Survival time (in months) was expressed as mean ± stand-
ard deviation (measured in months, presented as Kaplan-
Meier survival curves). Differences in survival times were
assessed by Mantel Cox statistic.
Results
As schematically shown in Figure 1, a total number of 200
patients (mean age ± SD: 62.4 ± 17.0 years old, 91 males)
were re-examined, the overall attendance rate for those
still living in the area of Spili reaching 80.7% (Table 1). In
order for our data to be comparable to the initial study,
results are presented with the population divided into the
same age groups used in 1988 (≤ 44, 45–64, 65–79) [15]
with the addition of a fourth one (≥80), due to aging
(Table 2). Forty-eight subjects (27 males and 21 females)
refused our invitation since "they felt in good health" and
they had very demanding working activities restricting
their free time. This subgroup of "non-attendees" did not
differ significantly in terms of age (χ2 = 1.435, df = 2, p =
0.488), sex (χ2 = 1.794, df = 1, p = 0.180) or their baseline
calculated FRS (p = 0.120) compared to those re-exam-
ined. Another 37 subjects (17 males, most of them in the
younger age group) had meanwhile left the area of Spili,
this representing an access barrier.
The average values of the most common determinants for
cardiovascular disease are presented in Table 2. One
should note the particularly high levels of systolic blood
pressure (146.8 ± 22.9 for men and 144.2 ± 25.2 mmHg
for women, respectively), fasting blood glucose (98.3 ±
38.6 and 98.7 ± 48.6 mg/dl) and cholesterol (198.3 ± 42.0
and 196.9 ± 36.1 mg/dl, respectively). Obesity, as
expressed with the BMI and waist circumference values
represents another issue with the average values for our
population being well above normal limits, particularly
for the subset of women exceeding the age of 65 (30.8 ±
4.7 kg/m2 for those aged 65–79 years).
Comparing the recently obtained data to the baseline
characteristics of our population in 1988, presented in
Table 3, we observe an increase in the prevalence of hyper-BMC Public Health 2007, 7:351 http://www.biomedcentral.com/1471-2458/7/351
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tension in almost every age group examined, for both
sexes (60.5% of men – 52 subjects and 65.1% of women
– 71 subjects). A similar unfavorable tendency is observed
for diabetes, particularly in women, while obesity repre-
sents these days a more important problem compared to
1988. Smoking habits have almost remained unchanged
with the exception of middle aged women (45–64 years,
not shown in the table) where it has significantly
increased (1 case in 1988 compared to 7 cases in 2001, p
< 0.001). Cholesterol levels have decreased compared to
baseline in most of the age groups of our population, for
both sexes (p < 0.05 for both men and women).
The described risk profile modification and the popula-
tion gradual aging, lead to a significant increase of the cal-
culated Framingham Risk Score (t = 15.764, df = 196, p <
0.001), as shown in Figure 2. Moreover, as reported in
Table 4, a 25.5% of those characterized as "low-risk" in
1988 (10-year estimated absolute risk for developing cor-
onary heart disease less than 15%) and 78.6% of those in
"medium-risk" category (15–25%) were classified in 2001
as "high-risk" (>25%) regarding the likelihood for future
coronary events. A reverse risk profile modification was
not observed since merely 4 subjects characterized in
1988 as "medium or high-risk" were classified in 2001 in
a lower risk category (McNemar-Bowker test χ2 = 104.790
df = 3, p < 0.001).
Using death certificates, Practice's medical registry and
information personally obtained during the interviews,
we identified a total number of 21 events indicative of
CHD in our population (14 cases of myocardial infarction
Table 1: Population analysis based on participation in second phase
Participation Age groups (1988)
≤ 44 45–64 65–79 Total
Participants in phase 2 Sex Male 36 (39.6%) 44 (48.4%) 11 (12.1%) 91
Female 40 (36.7%) 43 (39.4%) 26 (23.9%) 109
T o t a l 7 68 73 7 2 0 0
Deceased Sex Male 3 (12.0%) 6 (24.0%) 16 (64.0%) 25
Female 0 (0.0%) 8 (34.8%) 15 (65.2%) 23
Total 3 14 31 48
Moved from the area Sex Male 14 (82.4%) 1 (5.9%) 2 (11.8%) 17
Female 14 (70.0%) 2 (10.0%) 4 (20.0%) 20
Total 28 3 6 37
Not participants Sex Male 15 (55.6%) 10 (37.0%) 2 (7.4%) 27
Female 7 (33.3%) 10 (47.6%) 4 (19.0%) 21
Total 22 20 6 48
Attendance for the Spili cohort in phase 2, according to their sex and age group. Participation has been calculated according to the age group the 
subjects belonged at baseline evaluation.
Table 2: Common determinants for cardiovascular disease in the population (mean values ± SD)
MALES
Age groups (phase 2) SBP (mmHg) DBP (mmHg) Glu (mg/dl) Chol (mg/dl) Tg (mg/dl) HDL (mg/dl) BMI (kg/m2)W a i s t  ( c m )
≤ 44 years (n = 18) 128.3 ± 12.5 86.6 ± 9.8 80.6 ± 9.1 178.4 ± 33.1 96.6 ± 30.0 42.3 ± 13.7 26.8 ± 4.0 96.3 ± 12.0
45–64 years (n = 28) 148.8 ± 21.7 95.6 ± 13.3 94.8 ± 44.1 193.8 ± 34.9 131.8 ± 68.5 44.0 ± 10.4 26.3 ± 3.1 97.0 ± 8.2
65–79 years (n = 37) 151.6 ± 23.5 88.5 ± 13.5 108.0 ± 43.3 204.3 ± 44.5 112.8 ± 64.3 49.7 ± 13.8 26.8 ± 4.1 100.0 ± 11.1
≥ 80 years (n = 8) 158.8 ± 23.4 86.9 ± 13.6 105.8 ± 18.8 231.3 ± 51.0 150.1 ± 95.5 42.4 ± 11.9 26.4 ± 3.5 96.3 ± 6.2
Total (n = 91) 146.8 ± 22.9 90.2 ± 13.1 98.3 ± 38.6 198.3 ± 42.0 118.7 ± 64.6 45.8 ± 12.9 26.6 ± 3.7 98 ± 10.1
FEMALES
≤ 44 years (n = 16) 118.0 ± 10.7 78.3 ± 7.7 80.9 ± 8.6 172.8 ± 30.5 74.4 ± 36.0 51.1 ± 11.3 23.2 ± 2.0 78.8 ± 7.0
45–64 years (n = 33) 135.2 ± 21.8 84.9 ± 11.2 86.9 ± 20.4 197.2 ± 34.6 103.6 ± 30.3 47.4 ± 14.5 29.3 ± 3.8 94.0 ± 11.4
65–79 years (n = 31) 153.4 ± 21.2 86.6 ± 9.8 112.5 ± 73.3 207.7 ± 34.3 121.9 ± 72.0 51.5 ± 14.8 30.8 ± 4.7 97.7 ± 11.4
≥ 80 years (n = 23) 160.5 ± 23.9 82.5 ± 12.9 105.8 ± 36.8 195.9 ± 38.4 135.9 ± 59.6 52.5 ± 18.7 28.3 ± 4.4 98.2 ± 11.4
Total (n = 109) 144.2 ± 25.2 84.0 ± 10.9 98.7 ± 48.6 196.9 ± 36.1 112.4 ± 57.5 50.4 ± 15.1 28.7 ± 4.7 93.9 ± 12.6
The number of subjects for each group is displayed in parenthesis. These values refer to data collected in 2001. SBP: Systolic Blood Pressure, DBP: 
Diastolic Blood Pressure, Glu: Glucose, Chol: Cholesterol, Tg: TriglyceridesBMC Public Health 2007, 7:351 http://www.biomedcentral.com/1471-2458/7/351
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or CHD death and 7 cases of unstable angina and angina
pectoris), over the follow up period of 12 years. A survival
curve was plotted for the disease-free intervals of each one
of the FRS groups discussed (Figure 3). Our data indicate
a definite dissociation among the curves, since the 6th year
of follow up, with more CHD events occurring in the
medium and high risk groups (log-rank χ2 = 13.828, df =
2, p < 0.001). Isolating the subset of patients in the high-
est risk group (FRS > 25% in 1988), we identified 10 sub-
jects (representing 46% of the total number of 22) who
remain still alive at the end of the follow up period in
2001, 7 of them with no apparent signs of cardiovascular
disease. Overall, five subjects (22%) of the high risk group
developed CHD throughout the follow up period, while
twelve subjects (54%) had no signs of cardiovascular dis-
ease and were either still alive or had died of a different
cause.
The overall occurrence rate of CHD events was calculated
at 7.1 per 1000 person-years (95% CI: 6.8–7.3), while the
corresponding values for the three FRS groups were 2.9
per 1000 person-years (95% CI: 2.8–3.1) for the low, 15.2
per 1000 person-years (95% CI: 14.0–16.3) for the
medium and 18.9 per 1000 person-years (95% CI: 16.7–
21.2) for the high risk group respectively.
Discussion
This follow up study underlines that the unfavorable risk
profile identified in 1988 [15], for most of the common
determinants of cardiovascular disease, is still present.
However, signs of clinically evident CHD were scarce,
both at baseline and at follow up evaluation. To the best
of our knowledge there are very limited data in the litera-
ture concerning epidemiological studies, where a geo-
graphically well-defined population is monitored over
time without the application of any large scale interven-
tion.
Multiple epidemiological studies, some of them based on
population samples of the Seven Countries study, provide
evidence regarding the unfavorable risk profile modifica-
tion of the Greek population and an increasing tendency
in CHD prevalence [10,28,29]. In the area of Spili, the
unfavorable risk profile not only remains, but seems to get
even worse, with most of the indices exceeding those of
the urban (and also younger) cohort in the ATTICA study
[30]. Smoking habit is very frequent among men (more
than 40% of the male population are active smokers)
while it has become more common in women. Hyperten-
sion, diabetes and dyslipidaemia are present in alarming
rates and the same is the case for obesity, which has signif-
icantly increased, probably as a result of the sedentary life
style (following the shift from farming to other forms of
occupational activity). The increasing prevalence of
hypertension or metabolic disorders can likewise be con-
sidered a 'natural' epiphenomenon of the aging process
[31]. The statement is doubted however by other studies,
like the one performed among a Tanzanian, Brazilian and
Italian population, where blood pressure was correlated
with age only in the latter two cohorts whereas in the Afri-
can population who consumed a low salt "fish and vege-
table" diet, blood pressure did not increase with age [32].
The only favorable risk factor modification we report is a
slight cholesterol level decrease compared to baseline, a
common finding to other epidemiological studies in
European populations, mainly attributed to dietary
changes [33,34].
Modifications regarding the prevalence of most common
risk factors are quantified and easier perceived with the
calculation of FRS for both time points (1988 and 2001)
in our population. Only a minority seems to remain in the
same risk group category or reduce its chances for future
coronary events while the vast majority has moved into
higher risk groups, confirming evidence from previous
epidemiological studies carried out in Cretan cohorts
[10,28]. Considering the fundamental effect of aging in
FRS calculation, this would not be unexpected twelve
years past the initial evaluation. However, FRS is esti-
mated to be much higher in 2001, compared to 1988,
even when similar age groups are compared (Figure 2).
FRS seems to overestimate the risk for coronary events in
European populations and certain literature reports argue
Table 3: Prevalence of most common risk factors, for both sexes, in 1988 and 2001
Males Females
2001 1988 p 2001 1988 p
Hypertension (%) 52 (60.5%) 33 (20.6%) <0.001 71 (65.1%) 71 (41.0%) <0.001
Diabetes (%) 10 (12.0%) 11 (6.9%) 0.065 11 (12.8%) 15 (8.7%) <0.001
Hypercholesterolemia (%) 36 (43.4%) 101 (63.1%) <0.001 37 (43.0%) 105 (60.7%) <0.001
Increased w.c ( > 102 cm –  > 88 cm, %) 27 (32.5%) 25 (15.6%) <0.001 50 (58.1%) 83 (48.0%) <0.001
Current smokers (%) 37 (44.6%) 73 (45.6%) 0.454 12 (14.0%) 18 (10.4%) 1.000
w.c: waist circumference, : males, : femalesBMC Public Health 2007, 7:351 http://www.biomedcentral.com/1471-2458/7/351
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against its use [35-37]. In our study, it has successfully
identified subjects with the highest risk for development
of coronary events. The survival curves plotted in Figure 3,
indicating periods free of fatal or non-fatal coronary
events, demonstrate a clear dissociation, early during the
follow up period, among the three predefined risk groups.
Certain methodological issues in some of the aforemen-
tioned studies [36] can partly explain the reduced inci-
dence of CHD events recorded; the absence of an
electrocardiogram screening and therefore the inability to
identify cases of silent ischemia (rather common particu-
larly in the elderly women and diabetics) is one of them.
In certain cases, an obscure medical history may lead to
failure to classify certain sudden deaths related to coro-
FRS in 1988 and 2001 Figure 2
FRS in 1988 and 2001. Framingham Risk Score (FRS) scatter plots in comparable age groups at baseline (1988, Phase I) and 
follow up (2001, Phase II).
Table 4: Framingham Risk Score modifications through time (1988 – 2001)
FRAMINGHAM RISK SCORE 2001
<15% 15–25% >25% Total
FRAMINGHAM RISK SCORE 1988 <15% 62 (42.8%) 46† 31.7%) 37† (25.5%) 145 (100%)
15–25% 2‡ (4.8%) 7 (16.7%) 33† (78.6%) 42 (100%)
>25% 0 (0.0%) 2‡ (20.0%) 8 (80.0%) 10 (100%)
Total 64 (32.5%) 55 (27.9%) 78 (39.6%) 197 (100%)
Distribution of the participants in the three FRS groups and modifications through time. We can see that only 4 subjects (‡) moved to a lower FRS 
group in 2001 compared to baseline, while the vast majority (†) has worsen its profile.BMC Public Health 2007, 7:351 http://www.biomedcentral.com/1471-2458/7/351
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nary heart disease as such. This was not the case in our
study, where the population was closely monitored
thanks to an efficient 'primary care surveillance' program,
with all valuable information examined (prior to registra-
tion) in terms of reliability and 'cross checked' plausibil-
ity.
Over the 12 years of follow up and for the 248 subjects
monitored (200 who were re-examined and 48 who died
and whose medical records and death certificates were
examined) we identified only 21 coronary events, 10 of
them fatal. Despite the fact that the small numbers (of
both the sample size and events) do not allow us to draw
safe conclusions, the calculated occurrence rate of 7.1
(95% CI: 6.8–7.3) CHD events per 1000 patient-years
seems rather low considering the aforementioned risk
profile and the advanced age of our population sample.
Previous reports have also demonstrated an impressive
survival for the Cretan cohort compared to others of the
Seven Countries Study, despite the increased prevalence
of risk factors for cardiovascular disease [38]. An adequate
explanation however, is lacking.
Limitations
A major limitation of this study has to do with the 85 sub-
jects who were initially examined in 1988 and were not re-
assessed in 2001. Almost half of them (48 subjects)
refused our invitation while 37 could not be accessed
since they were not living in the area anymore. Our statis-
tical analysis reveals that, based on baseline characteris-
tics, those who refused our invitation were not statistically
different in terms of age, sex or calculated FRS compared
to participants. We can therefore assume that having those
subjects re-examined, our results wouldn't be significantly
different. On the other hand, those who have meanwhile
left the area, mostly belonging to the younger age groups,
would only be expected to show limited incidence rank-
ing of coronary artery disease. We therefore have reasons
to believe that even if those patients had been
Survival curves according to the FRS group Figure 3
Survival curves according to the FRS group. Coronary Heart Disease survival free curves for each one of the FRS 
groups. Test of equality of survival distributions for different FRS groups: Log Rank (Mantel-Cox) χ2 = 13.828, df = 2, p < 0.001.BMC Public Health 2007, 7:351 http://www.biomedcentral.com/1471-2458/7/351
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approached, the reported CHD morbidity and mortality
would have only been (if at all) favorably affected.
Another limitation of the present study is that there were
only single measurements of relevant risk factors that can
be rather misleading particularly for the diagnosis of
hypertension. When this study was initiated, this specific
matter constituted an issue of major speculation. The dif-
ficulty was overcome with the thorough use of Spili Prac-
tice medical records where multiple readings were usually
recorded for each one of our patients. When a definite and
solid conclusion could not be drawn, a re-evaluation visit
was scheduled within a two-month period.
Conclusion
The study confirms the unfavorable risk factor profile of a
well defined rural population in Crete. However, the ini-
tial question that has inspired this project since 1988
remains illusive. The assumption that closely knit social
networks may be associated with the good health status
Cretans enjoy [15] remains still unanswered. Arguments
referring to the presence of a protective factor (or condi-
tion) against the development of CHD in the population
have to be further supported. Other parameters, determin-
ing the health asset of a population, like dietary habits
(including the consumption of Cretan herbs among resi-
dents of the Spili area [39]) and the influence of the tradi-
tional Cretan social network were not included in this
study. An ongoing study that monitors the Spili cohort
and associates CHD rates with psychological scales, meas-
uring stress management, could further explore the links
between different coronary morbidity patterns and spe-
cific socio-cultural influences.
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